Skip to main content

Advertisement

Contact Stefano Rusconi

From: Efficacy and safety of a dual boosted protease inhibitor-based regimen, atazanavir and fosamprenavir/ritonavir, against HIV: experience in a pediatric population

Contact corresponding author